Filing Flows › InspireMD (NSPR) › Q1 2026 › vs Q1 2025
InspireMD (NSPR) Q1 2026 vs Q1 2025 (year over year)
InspireMD's revenue rose $1.9M (+122%) from $1.5M in Q1 2025 to $3.4M in Q1 2026.
InspireMD, Q1 2026: revenue $3.4M (+122% year over year), operating margin -411.4%, net loss $13.7M, operating cash flow −$12.3M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $3.4M | $1.5M | $1.9M | +122% |
| Other income, net | $289K | $294K | −$5K | -2% |
| Net loss | $13.7M | $11.2M | $2.5M | +23% |
| Costs & expenses | $17.4M | $13.0M | $4.4M | +34% |
| Operating costs | $17.4M | $13.0M | $4.4M | +34% |
| Cost of revenue | $2.7M | $1.2M | $1.5M | +119% |
| Research & development | $4.8M | $4.1M | $704K | +17% |
| Sales & marketing | $5.2M | $2.8M | $2.4M | +88% |
| General & admin | $4.7M | $4.9M | −$221K | -4% |
| Operating cash sources | $14.6M | $11.6M | $3.0M | +26% |
| Depreciation | $149K | $98K | $51K | +52% |
| Share-based compensation | $2.1M | $2.7M | −$624K | -23% |
| Cash used in operations | $12.3M | $8.8M | $3.5M | +40% |
| Net loss absorbed | $13.7M | $11.2M | $2.5M | +23% |
| Working capital & other | $902K | $453K | $449K | +99% |
Questions
How much did InspireMD's revenue grow year over year in Q1 2026?
InspireMD's revenue rose $1.9M (+122%) from $1.5M in Q1 2025 to $3.4M in Q1 2026.